CORT
NASDAQ · Pharmaceuticals
Corcept Therapeutics Inc
$71.63
-7.59 (-9.58%)
Performance
1D
—
1W
-11.70%
1M
-40.11%
3M
-37.29%
6M
+39.90%
1Y
-1.96%
YTD
+87.51%
Open$77.88
Previous Close$79.22
Day High$78.99
Day Low$71.52
52W High$126.38
52W Low$28.66
Volume—
Avg Volume1.07M
Market Cap9.06B
P/E Ratio164.10
EPS$0.43
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$109.43
Below
SMA 200
$75.45
Below
RSI (14)
17.9
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+42.9% upside
Current
$71.63
$71.63
Target
$102.33
$102.33
$62.31
$102.33 avg
$121.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 668.41M | 540.17M | 785.70M |
| Net Income | 87.48M | 63.63M | 178.89M |
| Profit Margin | 13.1% | 12.4% | 22.8% |
| EBITDA | 40.33M | 30.96M | 255.84M |
| Free Cash Flow | — | — | 116.31M |
| Rev Growth | +23.7% | +23.7% | +17.7% |
| Debt/Equity | — | — | 0.15 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |